Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-01

Clinical Trial Update: Effects of Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo on Lower Leg Growth in Prepubertal Children With Mild Persistent Asthma (6 to 12 y) (BY9010/M1-208) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing inhaled ciclesonide, fluticasone propionate, and placebo in prepubertal children with mild persistent asthma to assess effects on lower-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone propionate (Fluticasone propionate)
  • ciclesonide (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED